2252 logo

Shanghai MicroPort MedBot (Group) Co., Ltd. Stock Price

SEHK:2252 Community·HK$25.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

2252 Share Price Performance

HK$0
-16.46 (-100.00%)
HK$0
-16.46 (-100.00%)
Price HK$0

2252 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Exceptional growth potential with adequate balance sheet.

0 Risks
2 Rewards

Shanghai MicroPort MedBot (Group) Co., Ltd. Key Details

CN¥551.1m

Revenue

CN¥284.4m

Cost of Revenue

CN¥266.6m

Gross Profit

CN¥516.3m

Other Expenses

-CN¥249.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.24
48.38%
-45.30%
97.3%
View Full Analysis

About 2252

Founded
2014
Employees
464
CEO
Chao He
WebsiteView website
www.medbotsurgical.com

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People’s Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR’obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

Recent 2252 News & Updates

Recent updates

No updates